Vintage 2007 funds include Pitango's fifth fund - closed at $330 million; Pontifax II, which raised $85 million; Health Ventures, a new life sciences fund of $70 million; and Wanaka Capital Partners, fund of $45 million.
In addition, six Israeli venture capital funds announced first closings in 2007. These include two new cleantech funds - AquAgro and Israel Cleantech - and a new medical device fund, Agate Investments. Included, too, are Aviv Venture's second fund and two funds established by Israeli firms in partnership with foreign investors - SCP Vitalife and DFJ Tamir Fishman.
In the past ten years, Israeli VCs attracted a total of $10.6 billion. According to IVC; $2 billion in capital is currently available for investment by Israeli VCs, of which $1.2 billion is intended for First investments in high-tech companies and the remainder reserved for Follow-on investments. $800 million is expected to be raised in 2008 by Israeli VCs for investment in Israeli high technology over the next few years.
In 2007, Israeli venture capital funds raised a total of $1.1 billion by vintage year , twenty-one percent increase from the $903 million raised in 2006.